InsidersTradesSigma
Moberg Pharma AB (publ): directors' dealings · Finland · FIN-FSA
FI:moberg-pharma-ab-publSE0020353928FI·FIN-FSAMcap 503M€Healthcare
Explore the full management transaction log of Moberg Pharma AB (publ), a listed issuer based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Moberg Pharma AB (publ) has published 4 insider filings. Market capitalisation: €502.9m. The latest transaction was filed on 22 May 2026 (Purchase). Among the most active insiders: Lars Johansson. All data is free.
4
Insider Decl.
0
Thresholds
€44,358
4 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
10.70 €
Analyst consensus
1 analystsStrong buy
14.00 €Target 14.00 €(+31%)14.00 €
Income statement
Revenue13.5 M€
Gross profit7.7 M€57% margin
Net income−27.2 M€-201.2% margin
Valuation
PER (forward)53.5x
P/Book0.5x
Beta0.64
Balance sheet & cash
Market cap502.9 M€
Total debt2.5 M€
Free Cash Flow−60.7 M€
Debt / Equity2%
Profitability & ownership
% insiders12.1%
% institutions21.7%
Last declaration on 22 May 2026
Declarations4 total
Executives●Purchase20FIN-FSA
€9,77010,000 shares@ €0.9770.0019% mcap100.0% of flow
Aktie
FI:A003Y996-1·
Ideal exit: 16 Feb 2027 (T+270)
Executives●Purchase20FIN-FSA
€3,4344,711 shares@ €0.72890.0007% mcap100.0% of flow
Aktie
FI:A003Q210-1·
Ideal exit: 20 Mar 2026 (T+270)
Executives●Purchase20FIN-FSA
€29,32935,851 shares@ €0.81810.0058% mcap100.0% of flow
Aktie
FI:A003P585-1·
Ideal exit: 2 Mar 2026 (T+270)
Executives●Purchase20FIN-FSA
€1,8262,222 shares@ €0.82170.0004% mcap100.0% of flow
Aktie
FI:A003P274-1·
Ideal exit: 28 Feb 2026 (T+270)
4 of 4 declarations